The science of longer, healthier lives Scripps Research 2026-09-23 | The science of longer, healthier lives
Bringing precision therapy to mental disorders Scripps Research 2024-03-21 | Mental disorders like depression and schizophrenia affect the lives of millions of people around the world, and yet, available treatment options have remained the same for decades. In this free Front Row lecture, Scripps Research professor Hugh Rosen will share how his pioneering research led to the development of the drug navacaprant, which precisely targets one of the brain’s behavioral circuits and is currently in clinical testing for major depressive disorder. Harnessing his expertise as a physician-scientist, Rosen has discovered and developed multiple other medicines, including ozanimod—a breakthrough treatment approved for multiple sclerosis and ulcerative colitis.Learn more: https://www.scripps.edu/
Scripps Research Day Highlights Scripps Research 2024-02-28 | On February 15, 2024, Scripps Research celebrated its 100-year anniversary with “Scripps Research Day,” as declared by the City of San Diego. The event marked a century of life-saving discoveries, while also looking toward the future of scientific achievement. Scripps Research President and CEO Peter Schultz, PhD, and San Diego Mayor Todd Gloria gave remarks and shared the official city proclamation with Institute staff, scientists and students. Attendees enjoyed a photo booth, music, food, games, and a historic archives booth presented by Scripps Research Library.Learn more at https://100.scripps.edu/
How experiences shape the developing brain and impact neurological diseases Scripps Research 2024-02-23 | As we age, learn and grow over our lifetimes, the brain continually responds and adapts to what we experience. In this Front Row lecture, Scripps Research Chair of the Department of Neuroscience Hollis Cline revealed how sensory experiences shape the brain during development and aging—particularly visual experiences. Cline’s work has been critical in revealing how key visual brain circuits become disrupted in neurodevelopmental disorders, as well as in mapping the different communication pathways between neurons.Learn more: https://frontrow.scripps.edu/
Scripps Research Timeline: A Century of Science Changing Life Scripps Research 2024-02-07 | As Scripps Research celebrates our centennial, take a look at some of the major milestones over the past 100 years: from our founding in 1924, to our transformational leaders, and multiple Nobel Prize wins.Since its founding by philanthropist and journalist Ellen Browning Scripps in 1924, Scripps Research has remained at the forefront of science and medicine. Located in Torrey Pines, the institute now houses six research departments, multiple Nobel laureates and a top-ranked graduate school. Discoveries at Scripps Research have led to 15 approved medicines, including five invented within the institute’s labs. Scripps Research has also been an influential force in shaping the bioscience community atop the Torrey Pines Mesa, which is now a thriving and collaborative ecosystem of academic institutions, biopharmaceutical companies and nonprofit organizations.As Scripps Research enters a new century, the institute plans to expand its global impact on science and human health. Researchers will continue pursuing bold, transformative ideas, while translating these foundational discoveries into life-saving medicines. These are aimed at treating a spectrum of severe conditions, including cancer, neurological disorders, infectious diseases and much more. Visit our Centennial website to learn more: https://100.scripps.edu/
The importance of lipid nanoparticles in the COVID-19 vaccine #shorts #science #podcast Scripps Research 2024-02-06 | In this Ground Truths podcast with Eric Topol, Nobel prize winner Katalin Karikó discusses the importance of the lipid nanoparticles in the development of the COVID-19 vaccines.For more from Ground Truths, visit:youtube.com/@UCchFl-hJ98OejRXz2cYKMrQ erictopol.substack.com
Making science matter: A vision for a new century of life-changing science Scripps Research 2024-01-12 | In the inaugural lecture of the 2024 Centennial Front Row series, President and CEO Peter Schultz illuminates how Scripps Research is building on its storied past—a remarkable century of discovery and innovation—to establish a new paradigm for the future of science and medicine. Under Schultz’s leadership, Scripps Research is expanding its global impact by empowering exceptional scientists to pursue groundbreaking ideas and seamlessly blending curiosity-fueled science with impact-driven drug discovery. Schultz shares how this unique approach is already giving rise to a new generation of first-in-class medicines against cancers, heart disease, deadly pathogens, neurological disorders, and many other health threats.Learn more: https://www.scripps.edu/
Scripps Research: A Century of Science Changing Life Scripps Research 2024-01-04 | This year, Scripps Research is celebrating 100 years of Science Changing Life. Since its founding by philanthropist and journalist Ellen Browning Scripps in 1924, Scripps Research has remained at the forefront of science and medicine with six research departments, multiple Nobel laureates and a top-ranked graduate school.Visit the newly launched https://100.scripps.edu/ to hear scientists’ stories and discover the latest research in immunology, chemistry, drug discovery, infectious disease, neuroscience and individualized medicine. Dive into the institute’s world-renowned educational efforts, explore an interactive timeline and stay up to date on the latest scientific news.
Fly through Scripps Research: A Century of Science Changing Life Scripps Research 2024-01-04 | Ever wondered what goes on inside one of world's top scientific research institutes? Take a unique tour with this incredible flythrough of Scripps Research in La Jolla, California.Since 1924, Scripps Research has been at the forefront of uncovering biological insights, demystifying how our bodies work, and translating those discoveries into real-world impact. In 2024, the institute celebrates its centennial, a milestone that marks a century of seminal discoveries in immunology; infectious diseases (such as COVID, flu, HIV); neuroscience; heart disease; cancer; and more. The Institute has also made strides in groundbreaking chemistry advances, drug development and educational outreach efforts while contributing numerous findings that have improved human health around the world.Looking forward to the next 100 years of research, Scripps Research is committed to another century of Science Changing Life by advancing scientific understanding, educating the scientists of tomorrow, and impacting human health across the globe.https://100.scripps.edu/
Top Ranked Training: A Century of Science Changing Life Scripps Research 2024-01-04 | Innovation requires educating and training the next generation of scientific leaders. Since its founding in 1989, the Skaggs Graduate School of Chemical and Biological Sciences at Scripps Research has been ranked among the top 10 in the nation for PhD programs in Chemistry and Biological Sciences by U.S. News & World Report.Learn more:https://100.scripps.edu/https://education.scripps.edu/
An Engine for New Medicines: A Century of Science Changing Life Scripps Research 2024-01-04 | Calibr, a nonprofit research institute founded by Scripps Research President and CEO Peter Schultz, joined Scripps Research in 2018 as its drug discovery division.As a world-class nonprofit “bench to bedside” drug discovery engine, Calibr delivers groundbreaking solutions to unmet medical needs by uniting the creativity of fundamental discovery with highly focused R&D capabilities and expertise.Learn more: 100.scripps.edu
An Immunity Boost: A Century of Science Changing Life Scripps Research 2024-01-04 | In 1961, pioneering immunologist Frank Dixon established the Department of Experimental Pathology at the Scripps Clinic and Research Foundation, which would later become the basis of Scripps Research. Dixon served as director for 25 years, where his immunological focus would forever shape the institute’s scientific focus — as well as the world’s.Since Dixon’s leadership, scientists at Scripps Research have made countless discoveries revealing how the immune system functions and responds to different diseases. From designing universal vaccines for harmful viruses to uncovering the structures of deadly microbes, we are dedicated to translating our understanding of the immune system to eradicate disease worldwide.Learn more: 100.scripps.edu
Medicine Tailored to You: A Century of Science Changing Life Scripps Research 2024-01-04 | Every patient is unique, and scientists at the Scripps Research Translational Institute (SRTI) believe medicine should reflect this. Physician and professor Eric Topol founded SRTI in 2007 with a mission to individualize healthcare across the country, leveraging advancements in human genomics, wireless digital technologies, and artificial intelligence. SRTI is made up of leading scientists and clinical investigators who collaborate to understand the specific genetic, behavioral, and lifestyle factors that contribute to human health and ultimately help transform them.Learn more: 100.scripps.edu
Exploring the Atomic World: A Century of Science Changing Life Scripps Research 2024-01-04 | Chemistry is known as the “central science,” playing a fundamental role in enabling and integrating other scientific disciplines. Scripps Research is home to some of the world’s leading chemists, who advance our ability to design and produce molecules, develop life-changing therapies, and tackle global sustainability challenges.Former Scripps Research president Richard Lerner was integral to establishing the Institute as a world leader in chemistry and chemical biology. Serving as the institute’s leader from 1987 through 2012, Lerner believed chemistry and biology were inextricably linked, and studying these connections would unlock a new era in science and medicine.Learn more: 100.scripps.edu
Combating Microbial Threats: A Century of Science Changing Life Scripps Research 2024-01-04 | Every day, scientists at Scripps Research are discovering and developing new treatments to combat today’s infectious disease threats — and tomorrow’s. Many of these researchers played a significant role in the COVID-19 pandemic, including identifying new antibody treatments and uncovering the virus’ structure. Meanwhile, they are also applying these key learnings to better prepare the global population for whichever microbial threat emerges next.Learn more: 100.scripps.edu
Cracking the Neural Code: A Century of Science Changing Life Scripps Research 2024-01-04 | The brain remains one of the most complex and mysterious parts of the human body, controlling everything from how we move to where we store and process memory. Scripps Research neuroscientists are helping us understand the mechanisms of why we age, what drives neurodegenerative diseases like Alzheimer’s and Parkinson’s, how the brain communicates with the rest of the body, and more. By evaluating the brain at multiple levels, these researchers are shedding light on the mysteries that have perplexed the field for decades.Learn more: 100.scripps.edu
Tony Wyss-Coray: The Science of Aging Scripps Research 2023-12-28 | The science to advance our understanding of the aging process—and to potentially slow it down—has made important strides. One of the leading scientists responsible for this work is Professor Tony Wyss-Coray, whose work has particularly focused on brain aging but has implications for all organs. I believe his December 2023 Nature paper on blood proteins that can track aging for 11 of our organs is one of the most important aging reports yet.Listen to more episodes here: erictopol.substack.com
New AI-powered algorithm could better assess people’s risk of common heart condition Scripps Research 2023-12-12 | LA JOLLA, CA—A new artificial intelligence (AI) model designed by Scripps Research scientists could help clinicians better screen patients for atrial fibrillation (or AFib)—an irregular, fast heartbeat that is associated with stroke and heart failure. The model picks up on tiny variations in a person’s normal heartbeat that signify AFib risk, which standard screening tests cannot detect. The findings, described in the journal npj Digital Medicine on December XX, 2023, used data on nearly half a million people who had each worn an electrocardiogram (ECG) patch to record their heart rhythms for two weeks—a routine screening test for AFib and other heart conditions. An AI model then analyzed this data to find patterns, other than AFib itself, that distinguished people with AFib from those without. This new model holds the potential to better detect those who are at risk for AFib and ultimately prevent this heart condition’s severe side effects, including stroke and heart failure. “With this new tool, we can better identify patients at high risk of AFib for further tests and interventions,” says senior author Giorgio Quer, PhD, director of artificial intelligence at Scripps Research Translational Institute and an assistant professor of digital medicine at Scripps Research. “Long term, this can help drive the right resources to the right people and potentially reduce the incidence of stroke and heart failure.”The irregular heartbeat due to AFib can cause blood to pool in the heart and form blood clots, which can then contribute to strokes. AFib is also associated with an increased risk of heart failure or death. To prevent these complications in people with known AFib, clinicians often prescribe anticoagulants—drugs that prevent blood clots— as well as other lifestyle and medical therapies. However, diagnosing AFib can be tricky because many with the condition only have occasional bouts of the irregular heartbeat, or few symptoms. In some people, AFib causes heart palpitations, lightheadedness, shortness of breath and chest pain. For patients who have these symptoms, cardiologists usually record the heart rhythms for about ten seconds in their office using a very detailed ECG that includes ten electrodes placed on the body. If nothing seems immediately amiss, they recommend continued, at-home monitoring for one or two weeks with a simpler, wearable ECG patch that has just a single electrode. But even over a two-week span, people with very occasional AFib may not have an episode picked up by this device. That is why Quer, in collaboration with iRhythm Technologies (the maker of a wearable electrocardiogram patch called the Zio®XT), set out to find other patterns in the ECG data of people with AFib. “We believe the electrical activity of the heart is slightly different for people who have AFib, but the differences are so subtle that cardiologists can’t look at a printout of heart rhythms and identify these differences,” says Quer. The team developed a machine learning model to analyze data that iRhythm had collected on 459,889 people who wore the company’s at-home ECG patch for two weeks. From each ECG, the model used one day of data which contained no AFib. However, it was able to distinguish people who had later AFib from those who didn’t. Even when the researchers integrated all known AFib risk factors into their own, manual models—including demographic data and ECG measures such as the variability between different heart beats—the machine learning model was more accurate at predicting AFib risk. “There was a gap between what we could achieve with any known ECG features and what the model could achieve,” says Matteo Gadaleta, PhD, a professional scientific collaborator at the Translational Institute and first author of the paper. “It was significantly better.”Importantly, the model remained accurate for both an older population, who are at higher risk of AFib, and people under the age of 55, who are at much lower risk and are usually excluded from general AFib screening. While the model is not intended for the diagnosis of AFib, it is a first step towards the design of a screening test for people who are at increased risk of AFib or those showing symptoms. This way, they could wear an ECG patch for just one day to determine whether longer testing is recommended. Alternatively, the model could analyze one- or two-week ECG data to pinpoint patients who, even without any AFib in that timeframe, should have a repeat test. “Patients with frequent AFib episodes can be identified easily with an ECG recorded over at least a week,” says Quer. “But this AI model could really help with people who have very infrequent AFib episodes yet could still benefit from diagnosis and intervention.”Quer and his colleagues hope to plan a prospective study, as well as integrate other sources of data—such as electronic medical records—into their models to improve them even more.
David Liu: A Master Class on the Future of Genome Editing Scripps Research 2023-12-12 | David Liu is an gifted molecular biologist and chemist who has pioneered major refinements in how we are and will be doing genome editing in the future, validating the methods in multiple experimental models, and establishing multiple companies to accelerate their progress.The interview that follows here highlights why those refinements beyond the CRISPR Cas9 nuclease (used for sickle cell disease) are vital, how we can achieve better delivery of editing packages into cells, ethical dilemmas, and a future of somatic (body) cell genome editing that is in some ways is up to our imagination, because of its breadth, over the many years ahead.Listen to more episodes here: erictopol.substack.com
Geoffrey Hinton: Large Language Models in Medicine. They Understand and Have Empathy Scripps Research 2023-12-08 | In this edition of the Ground Truths podcast, Geoffrey Hinton, PhD - the "Godfather of AI" - and Eric Topol, MD, discuss all things A.I. and large language models. Listen to more episodes here: erictopol.substack.com
Editing genes to tackle neurological conditions: Front Row Lecture with Xin Jin, PhD Scripps Research 2023-11-30 | Networks of genes coordinate the formation of brain cells during early life development. However, diverse genetic variants can impact this process and ultimately manifest in different brain disorders and developmental disabilities. In this Front Row lecture, Scripps Research assistant professor Xin Jin will share how her lab is using cutting-edge technology to discover which brain regions and cell types are involved in disease pathology. Jin’s insights are revealing neurodevelopmental and other disorders, as well as defining a path for new diagnostic tools and therapeutic interventions.Learn more: https://frontrow.scripps.edu/
Andrew Ng: AI regulation, education, and where we are headed for healthcare and beyond Scripps Research 2023-11-21 | Eric Topol welcomes Coursera Co-founder and AI expert Andrew Ng to the Ground Truths podcast.For more from Ground Truths, visit: erictopol.substack.com
Bruce Wilkoff: A pioneering cardiologist who dedicated his career to preventing sudden death Scripps Research 2023-11-20 | My conversation with Dr. Bruce Wilkoff, one of the leading experts of heart pacemakers and defibrillators in the world. We were colleagues working together for 14 years at Cleveland Clinic (1991-2005). Now he’s facing death from metastatic pancreatic cancer and has a remarkably upbeat perspective to share.For more from Ground Truths, visit: erictopol.substack.com
How well to AI detectors work? #shorts Scripps Research 2023-11-13 | A podcast with James Zou, a Stanford computer scientist who is lighting it up in life science and medical A.I. Recent papers discussed in this podcast include degradation of GPT-4 performance, using large language models for peer review, and taking more than 200,000 pathology posts from Twitter to build a visual-language model.For more from Ground Truths, visit: erictopol.substack.com
Could AI help with peer review on scientific papers? #shorts Scripps Research 2023-11-10 | A podcast with James Zou, a Stanford computer scientist who is lighting it up in life science and medical A.I. Recent papers discussed in this podcast include degradation of GPT-4 performance, using large language models for peer review, and taking more than 200,000 pathology posts from Twitter to build a visual-language model.For more from Ground Truths, visit: erictopol.substack.com
Can actors and CEOs survive on 4 hours of sleep? Sleep scientist weighs in. #shorts Scripps Research 2023-11-08 | A good night’s sleep is one of the keys to feeling good the next day. But how do we know if we’re getting enough?Doctor Stuti Jaiswal and her colleagues at the Scripps Research Translational Institute and the Digital Trials Center recently launched a study called REFRESH. It uses wearable data to track participants’ sleep. Since participants never have to go to a lab, researchers can see how they sleep over long periods of time, and gain insight into how sleep affects their health. As technology advances, and studies like refresh give researchers a better understanding of sleep, a day could come when everyone has the tools to sleep better.Learn more: https://refresh.scripps.edu/
Do large language models like GPT-4 degrade over time? #shorts Scripps Research 2023-11-08 | A podcast with James Zou, a Stanford computer scientist who is lighting it up in life science and medical A.I. Recent papers discussed in this podcast include degradation of GPT-4 performance, using large language models for peer review, and taking more than 200,000 pathology posts from Twitter to build a visual-language model.For more from Ground Truths, visit: erictopol.substack.com
Using Twitter and AI to diagnose medical images #shorts Scripps Research 2023-11-06 | A podcast with James Zou, a Stanford computer scientist who is lighting it up in life science and medical A.I. Recent papers discussed in this podcast include degradation of GPT-4 performance, using large language models for peer review, and taking more than 200,000 pathology posts from Twitter to build a visual-language model.For more from Ground Truths, visit: erictopol.substack.com
James Zou: one of the most prolific and creative A.I. researchers in both life science and medicine Scripps Research 2023-11-02 | A podcast with James Zou, a Stanford computer scientist who is lighting it up in life science and medical A.I. Recent papers discussed in this podcast include degradation of GPT-4 performance, using large language models for peer review, and taking more than 200,000 pathology posts from Twitter to build a visual-language model.For more from Ground Truths, visit: erictopol.substack.com
Rapamycins impact on healthspan: Peter Attia on Ground Truths with Eric Topol #shorts Scripps Research 2023-10-29 | Eric Topol sits down with Peter Attia to discuss his new book Outlive, Medicine 3.0, promoting healthspan, GLP-1 drugs and more.For more Ground Truths, visit: erictopol.substack.com
Preventing heart disease with machine learning and smartphone technology Scripps Research 2023-10-26 | Heart disease is the leading cause of death in the United States, yet our ability to predict and lower our own risk has been limited. In this Front Row lecture, Scripps Research professor Ali Torkamani will share how his team is developing app-based digital tools that can analyze genetic markers and predict someone’s future cardiovascular disease risk. Torkamani’s research is being integrated into remote clinical trials that can provide personalized behavioral and therapeutic interventions to improve long-term health outcomes.Register for future Front Row lectures:https://frontrow.scripps.edu/
How much protein do you need? Peter Attia on Ground Truths with Eric Topol #shorts Scripps Research 2023-10-26 | Eric Topol sits down with Peter Attia to discuss his new book Outlive, Medicine 3.0, promoting healthspan, GLP-1 drugs and more.For more Ground Truths, visit: erictopol.substack.com
The benefits of continuous glucose monitoring: Peter Attia on Ground Truths with Eric Topol #shorts Scripps Research 2023-10-24 | Eric Topol sits down with Peter Attia to discuss his new book Outlive, Medicine 3.0, promoting healthspan, GLP-1 drugs and more.For more Ground Truths, visit: erictopol.substack.com
Peter Attia: his hit book OUTLIVE, Medicine 3.0, promoting healthspan, GLP-1 drugs and more Scripps Research 2023-10-24 | Eric Topol sits down with Peter Attia to discuss his new book Outlive, Medicine 3.0, promoting healthspan, GLP-1 drugs and more.For more Ground Truths, visit: erictopol.substack.com
The incredible evolution of genome editing #shorts #podcast #crispr #genomeediting Scripps Research 2023-10-18 | Professor Urnov at UC Berkeley coined the term genome editing and spearheaded foundation work that led to the current world of CRISPR--the most extraordinary life science breakthrough of our time.Beyond being a brilliant scientist, Fyodor is an extraordinary communicator as you will hear/see with his automotive metaphors to explain genome editing and gene therapy. His recent NY Times oped confronts the critical issues that we face ahead.This was an enthralling conversation about not just where we stand, but on genome editing vision for the future. For more Ground Truths, visit: erictopol.substack.com
How CRISPR genome editing may impact disease #shorts #podcast #crispr #genomeediting Scripps Research 2023-10-16 | Professor Urnov at UC Berkeley coined the term genome editing and spearheaded foundation work that led to the current world of CRISPR--the most extraordinary life science breakthrough of our time.Beyond being a brilliant scientist, Fyodor is an extraordinary communicator as you will hear/see with his automotive metaphors to explain genome editing and gene therapy. His recent NY Times oped confronts the critical issues that we face ahead.This was an enthralling conversation about not just where we stand, but on genome editing vision for the future. For more Ground Truths, visit: erictopol.substack.com
The promise of CRISPR genome editing in human health #shorts #podcast #crispr #genomeediting Scripps Research 2023-10-13 | Professor Urnov at UC Berkeley coined the term genome editing and spearheaded foundation work that led to the current world of CRISPR--the most extraordinary life science breakthrough of our time.Beyond being a brilliant scientist, Fyodor is an extraordinary communicator as you will hear/see with his automotive metaphors to explain genome editing and gene therapy. His recent NY Times oped confronts the critical issues that we face ahead.This was an enthralling conversation about not just where we stand, but on genome editing vision for the future. For more Ground Truths, visit: erictopol.substack.com
On Genome Editing With Fyodor Urnov, A Pioneer: Ground Truths with Eric Topol Scripps Research 2023-10-12 | Professor Urnov at UC Berkeley coined the term genome editing and spearheaded foundation work that led to the current world of CRISPR--the most extraordinary life science breakthrough of our time.Beyond being a brilliant scientist, Fyodor is an extraordinary communicator as you will hear/see with his automotive metaphors to explain genome editing and gene therapy. His recent NY Times oped confronts the critical issues that we face ahead.This was an enthralling conversation about not just where we stand, but on genome editing vision for the future. For more Ground Truths, visit: erictopol.substack.com
A Celebration of Gratitude 2023 Scripps Research 2023-10-11 | On Thursday, October 5, 2023, invitees gathered for the second annual donor appreciation event: A Celebration of Gratitude. The event celebrates the donor impact on the transformative research and groundbreaking discoveries taking place at Scripps Research. This year’s program included a panel discussion and live Q&A featuring Arnab Chatterjee, PhD, Katja Lamia, PhD, and Tom Daniel, MD. After the program, guests were invited to explore interactive science stations.
Long journey to make hookworm vaccine: Peter Hotez #shorts Scripps Research 2023-09-19 | Dr. Peter Hotez is a veritable force. He has been the tip of the spear among physicians and scientists for taking on anti-science and has put himself and his family at serious risk. Along with Dr. Maria Bottazzi, he developed the Corbevax Covid vaccine —without a patent— that has already been given to over 10 million people, and was nominated for the Nobel Peace Prize. Learn more about Ground Truths: erictopol.substack.com/p/straight-talk-with-peter-hotez#details
Straight Talk with Peter Hotez: Ground Truths Podcast with Eric Topol Scripps Research 2023-09-19 | Dr. Peter Hotez is a veritable force. He has been the tip of the spear among physicians and scientists for taking on anti-science and has put himself and his family at serious risk. Along with Dr. Maria Bottazzi, he developed the Corbevax Covid vaccine —without a patent— that has already been given to over 10 million people, and was nominated for the Nobel Peace Prize. Learn more about Ground Truths: erictopol.substack.com/p/straight-talk-with-peter-hotez#details
Re-engineering a sustainable world Scripps Research 2023-09-14 | Since the dawn of life, nature has balanced the composition of our planet’s atmosphere by evolving elegant ways of capturing carbon dioxide. Today, humanity’s overuse of fossil fuels has altered this atmospheric balance to bring about environmental disruptions, and nature is poorly equipped to correct them. In this Front Row lecture, Scripps Research assistant professor Ahmed Badran will share how his lab is developing strategies inspired by plants to help sequester the rising levels of carbon dioxide. His breakthroughs in synthetic biology are guiding revolutionary environmental approaches that could make a lasting impact on the atmosphere and agricultural food systems.Register for future Front Row lectures: https://frontrow.scripps.edu/
Preparing for potential long term side effects of COVID #shorts Scripps Research 2023-09-14 | Few, if any, physician researchers have done more to understand the long-term impact of Covid than Dr. Ziyad Al-Aly, a professor, nephrologist, and epidemiologist along with his team at Washington University, St. Louis.Listen to more episodes here: erictopol.substack.com
Long COVID research and the many benefits of understanding this disease #shorts Scripps Research 2023-09-12 | Few, if any, physician researchers have done more to understand the long-term impact of Covid than Dr. Ziyad Al-Aly, a professor, nephrologist, and epidemiologist along with his team at Washington University, St. Louis.Listen to more episodes here: erictopol.substack.com
Illuminating Long Covid: Ground Truths Podcast with Ziyad Al-Aly and Eric Topol Scripps Research 2023-09-11 | Few, if any, physician researchers have done more to understand the long-term impact of Covid than Dr. Ziyad Al-Aly, a professor, nephrologist, and epidemiologist along with his team at Washington University, St. Louis.Listen to more episodes here: erictopol.substack.com
Should AI be used in scientific papers? Journal Nature editor weighs in #shorts Scripps Research 2023-08-25 | In this edition of the Ground Truths podcast, Magdalena Skipper, PhD, editor-in-chief of the journal Nature, and Eric Topol, MD, discuss how the journal navigated COVID, the future of scientific journals in the age of AI, and much more.Listen to more episodes here: erictopol.substack.com
Transforming treatment options for alcohol use disorder: Front Row lecture with Barbara Mason, PhD Scripps Research 2023-08-24 | Alcohol misuse has risen in recent years, yet the underlying causes of alcohol use disorder (AUD), as well as the future standard of care, remain unclear. In this Front Row lecture, Scripps Research professor Barbara Mason will share how her team is exploring the neurocircuitry involved in AUD and developing new medicines that could curb alcohol intake. Her research is identifying the most promising drug candidates for clinical trials and changing the way scientists view addiction, withdrawal and relapse.Register for future Front Row lectures:https://frontrow.scripps.edu/
How the journal Nature worked with preprints during the pandemic #shorts Scripps Research 2023-08-23 | In this edition of the Ground Truths podcast, Magdalena Skipper, PhD, editor-in-chief of the journal Nature, and Eric Topol, MD, discuss how the journal navigated COVID, the future of scientific journals in the age of AI, and much more.Listen to more episodes here: erictopol.substack.com
Is science becoming more gender balanced? #shorts Scripps Research 2023-08-21 | In this edition of the Ground Truths podcast, Magdalena Skipper, PhD, editor-in-chief of the journal Nature, and Eric Topol, MD, discuss how the journal navigated COVID, the future of scientific journals in the age of AI, and much more.Listen to more episodes here: erictopol.substack.com
Straight talk with Magdalena Skipper, the Editor-in-Chief at Nature: Ground Truths with Eric Topol Scripps Research 2023-08-19 | The first woman chief editor in Nature's 150-year history discusses Covid's impact on the journal, generative A.I., preprints, women in science, paywalls, and what keeps her up at nightListen to more episodes here: erictopol.substack.com
Can AI help us spot disease doctors miss? #shorts Scripps Research 2023-08-16 | In this edition of the Ground Truths podcast, John Halamka, MD, MS, and Eric Topol, MD, discuss how AI and large language models fit into the world of healthcare.Listen to more episodes here: erictopol.substack.com
